These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25648416)

  • 1. A visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology.
    Porras P; Duesbury M; Fabregat A; Ueffing M; Orchard S; Gloeckner CJ; Hermjakob H
    Proteomics; 2015 Apr; 15(8):1390-404. PubMed ID: 25648416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viewing the proteome: how to visualize proteomics data?
    Oveland E; Muth T; Rapp E; Martens L; Berven FS; Barsnes H
    Proteomics; 2015 Apr; 15(8):1341-55. PubMed ID: 25504833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization and analysis of biological networks.
    Millán PP
    Methods Mol Biol; 2013; 1021():63-88. PubMed ID: 23715980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 in Parkinson's disease: biochemical functions.
    Anand VS; Braithwaite SP
    FEBS J; 2009 Nov; 276(22):6428-35. PubMed ID: 19804416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology and pathobiology of LRRK2: implications for Parkinson's disease.
    Moore DJ
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 in Parkinson's disease: protein domains and functional insights.
    Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA
    Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.
    Krumova P; Reyniers L; Meyer M; Lobbestael E; Stauffer D; Gerrits B; Muller L; Hoving S; Kaupmann K; Voshol J; Fabbro D; Bauer A; Rovelli G; Taymans JM; Bouwmeester T; Baekelandt V
    FASEB J; 2015 Jul; 29(7):2980-92. PubMed ID: 25854701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine-rich repeat kinase 2: relevance to Parkinson's disease.
    Guo L; Wang W; Chen SG
    Int J Biochem Cell Biol; 2006; 38(9):1469-75. PubMed ID: 16600664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IIS--Integrated Interactome System: a web-based platform for the annotation, analysis and visualization of protein-metabolite-gene-drug interactions by integrating a variety of data sources and tools.
    Carazzolle MF; de Carvalho LM; Slepicka HH; Vidal RO; Pereira GA; Kobarg J; Meirelles GV
    PLoS One; 2014; 9(6):e100385. PubMed ID: 24949626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 in Parkinson's disease: building an understanding of disease etiology.
    Braithwaite SP
    FEBS J; 2009 Nov; 276(22):6427. PubMed ID: 19804417
    [No Abstract]   [Full Text] [Related]  

  • 11. VisANT: an online visualization and analysis tool for biological interaction data.
    Hu Z; Mellor J; Wu J; DeLisi C
    BMC Bioinformatics; 2004 Feb; 5():17. PubMed ID: 15028117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.
    Greggio E
    Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of LRRK2: from kinase to substrate.
    Lobbestael E; Baekelandt V; Taymans JM
    Biochem Soc Trans; 2012 Oct; 40(5):1102-10. PubMed ID: 22988873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
    Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M
    Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease.
    Gómez-Suaga P; Fdez E; Fernández B; Martínez-Salvador M; Blanca Ramírez M; Madero-Pérez J; Rivero-Ríos P; Fuentes JM; Hilfiker S
    Neuropharmacology; 2014 Oct; 85():45-56. PubMed ID: 24863040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Interaction Network Construction and Analysis for Disease Discovery.
    Wu G; Haw R
    Methods Mol Biol; 2017; 1558():235-253. PubMed ID: 28150241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies.
    Daniëls V; Baekelandt V; Taymans JM
    Neurosignals; 2011; 19(1):1-15. PubMed ID: 21430363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions.
    Drolet RE; Sanders JM; Kern JT
    J Neurogenet; 2011 Dec; 25(4):140-51. PubMed ID: 22077787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated web visualizations for protein-protein interaction databases.
    Jeanquartier F; Jean-Quartier C; Holzinger A
    BMC Bioinformatics; 2015 Jun; 16(1):195. PubMed ID: 26077899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.
    Estrada AA; Sweeney ZK
    J Med Chem; 2015 Sep; 58(17):6733-46. PubMed ID: 25915084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.